#Dana-Farber Cancer Institute

Her research and clinical care for people diagnosed with breast cancer is a model for cancer survivorship for anyone with any cancer.

A new study clarifies the benefits and risks of treatments for those with multiple myeloma, a blood cancer more common in Black Americans.

Latino children and those with public insurance had poorer survival even if they received the same treatment in clinical trials.

Experimental KRAS inhibitor adagrasib also shows activity against lung cancer that has spread to the brain.

Does red meat cause cancer? Does stress or Radon? CancerFactFinder.org offers evidence-based answers to such questions.

The clinical trial used a combo of Verzenio and Femara in patients with recurrent endometrial cancer that’s estrogen receptor positive.

A new type of treatment uses antibodies to deliver cancer-fighting drugs directly to tumors.

Adding radiation therapy to Imfinzi and tremelimumab didn’t help those with non-small cell lung cancer, according to a new study.

A combination of two immunotherapy drugs showed efficacy in the treatment of advanced melanoma in a phase 3 clinical trial.

A look at the symptoms, treatments, risk factors, prognosis and research on breast cancer metastasis to the brain.

P-NET is a “biologically informed deep learning model” capable of guessing a prostate cancer patient’s disease state.

Study is first to show benefit of any targeted drugs in glioblastomas—the most aggressive brain tumors.

Study findings from the Dana-Farber Cancer Institute arrive as colorectal cancer rates are increasing among younger people.

These findings highlight the importance of mutation-specific care in MPN, not only at diagnosis but in treatment counseling and follow-up.

Researchers looking at ovarian cancer cells that resist chemotherapy hope to develop new therapeutic strategies.

African Americans are twice as likely to be diagnosed with multiple myeloma as white people, but lag in treatment gains.